It suggests that once RA is established, the drivers of shoulder damage and disability may be more related to the current systemic inflammatory burden (reflected by Hb, PLT, TLC) and comorbid conditions (like hyperglycemia or vitamin D deficiency) than to the initial autoimmune serological profile. The gene discussed is GSTM1; the disease is rheumatoid arthritis.